Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    7.50 (3.19%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

23 Mar 2010 07:00

RNS Number : 9819I
Alumasc Group PLC
23 March 2010
 



Tuesday 23 March 2010

 

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

 

Alumasc (ALU.L), the premium building and engineering products company, is publishing its second interim management statement relating to the year ending 30 June 2010.

 

After a very difficult winter, when the Building Products division was impacted by continued weak construction markets exacerbated by the prolonged period of cold weather, there are signs that overall group activity levels are beginning to improve as Alumasc enters its seasonally stronger spring and early summer trading period. The group's order books have strengthened by 14% since the beginning of January.

 

Significant new work and specification wins in the current half year include:

·; solar shading projects worth £1.2 million relating to the London Olympics;

·; solar shading specifications valued at over £3 million in London and a further $1 million in the USA;

·; the supply of waterproofing and drainage products to a social housing project in Sheffield with a value in excess of £1 million over the remainder of this calendar year;

·; exterior wall insulation for a social housing refurbishment project in Scotland valued at around £3 million over four to five years; and

·; Precision Engineering work amounting to over £6 million for Deutz and £3 million for Caterpillar over a five year period.

 

Since December, Alumasc Precision Components, the group's largest Engineering Products business, has returned to profit due to improving revenues and the actions taken over the last 18 months to reduce costs substantially and increase operational efficiency. This improved performance will have a material positive turn-around effect on the Engineering Products division's second half performance compared with a year ago, when Alumasc Precision reported a second-half trading loss of £1.2 million.

 

The remaining £1 million tranche of the group's £8 million fixed cost reduction programme is expected to be fully delivered by the year end. In addition, the group's cash flow performance has continued to run ahead of expectations set both at the beginning of the year and at the half year stage, driven by continuing strong control of working capital and capital expenditure.

 

In view of the very difficult winter in the Building Products division and the contraction in demand for new commercial buildings, the group's result for the year to 30 June 2010 is now likely to be below the Board's previous expectations. However, the group's improving trading momentum and growing order book could still benefit the final months of the current financial year and leave Alumasc better placed as the new financial year begins.

 

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Charles Ponsonby/Rose Oddy Tel: 0207 367 8851

 

 

This Interim Management Statement has been drawn up and presented for the purposes of complying with English law. Any liability arising out of or in connection with this Interim Management Statement will also be determined in accordance with English law.

 

This Interim Management Statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors beyond The Alumasc Group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

 

Nothing in this Interim Management Statement is intended to be a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDLLFLBXFZBBV
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.